[Rational introduction to new drugs requires both a health care and a community perspective].
Gustafsson
Lars L
LL
Karolinska institutet, Karolinska Universitetssjukhuset Huddinge. lars-l.gustafsson@ki.se
Wettermark
Björn
B
Kalin
Mats
M
Korkmaz
Seher
S
Persson
Marie E
ME
Almkvist
Henrik
H
Hjemdahl
Paul
P
Julander
Margaretha
M
Kristianson
Krister
K
Ringertz
Bo
B
Bergendahl
Gunilla Thörnwall
GT
Wiking
Nils
N
D035843:Biomedical Research; D004059:Diffusion of Innovation; D016527:Drug Costs; D004341:Drug Evaluation / Q000379:methods*; D004345:Drug Industry; D015507:Drugs, Investigational / Q000191:economics / Q000627:therapeutic use*; D006801:Humans
D015507:Drugs, Investigational